Stockreport

Tiziana Life Sciences Expands Phase 2 Clinical Trial for Non-Active Secondary Progressive Multiple Sclerosis to Additional Prestigious U.S. Medical Centers [Yahoo! Finance]

Tiziana Life Sciences Ltd - Common Shares  (TLSA) 
PDF The Phase 2 clinical trial for intranasal foralumab is ongoing, and the trial sites include esteemed institutions across the Northeast of the United States, such as Yal [Read more]